We are live on ! Find out more
FATE icon

Fate Therapeutics
FATE

167 hedge funds and large institutions have $904M invested in Fate Therapeutics in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

324% more call options, than puts

Call options by funds: $1.69M | Put options by funds: $399K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

150% more capital invested

Capital invested by funds: $362M → $904M (+$542M)

32% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 31

25.92% more ownership

Funds ownership: 98.19% → 124.12% (+26%)

5% more funds holding

Funds holding: 159 → 167 (+8)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

Holders
167
Holders Change
+8
Holders Change %
+5.03%
% of All Funds
2.41%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
41
Increased
48
Reduced
52
Closed
31
Calls
$1.69M
Puts
$399K
Net Calls
+$1.29M
Net Calls Change
+$1.23M

Top Buyers

1
BC
Boxer Capital
California
+$47.8M
2
State Street
State Street
Massachusetts
+$38.2M
3
DTC
Deep Track Capital
Connecticut
+$34.5M
4
SCM
Suvretta Capital Management
New York
+$15.9M
5
Holocene Advisors
Holocene Advisors
New York
+$15.6M

Top Sellers

1
BlackRock
BlackRock
New York
-$13.1M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.8M
3
MAM
Monaco Asset Management
Monaco
-$11.6M
4
Two Sigma Investments
Two Sigma Investments
New York
-$7.96M
5
CC
Casdin Capital
New York
-$7.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
QCG
151
Quadrant Capital Group
Ohio
$3.23K +$2.72K +440 New
PNC Financial Services Group
152
PNC Financial Services Group
Pennsylvania
$3.19K -$619 -100 -19%
EWA
153
EverSource Wealth Advisors
Alabama
$2.69K – – –
HNB
154
Hilltop National Bank
Wyoming
$2.09K +$1.76K +285 New
BIA
155
Bell Investment Advisors
California
$1.91K – – –
AFG
156
Albion Financial Group
Utah
$1.65K – – –
National Bank of Canada
157
National Bank of Canada
Quebec, Canada
$1.63K -$40.9K -6,600 -94%
FDCDDQ
158
Federation des caisses Desjardins du Quebec
Quebec, Canada
$697 – – –
VCM
159
Versant Capital Management
Arizona
$609 – – –
EBA
160
Eagle Bay Advisors
New York
$558 – – –
PCA
161
Providence Capital Advisors
North Carolina
$448 – – –
CMBA
162
C.M. Bidwell & Associates
Hawaii
$220 – – –
EWM
163
Evermay Wealth Management
Virginia
$184 +$155 +25 New
AWM
164
Avior Wealth Management
Nebraska
$124 +$105 +17 New
AF
165
Allworth Financial
California
$30 – – –
CC
166
Casdin Capital
New York
– -$7.67M -2,050,000 Closed
SC
167
Stempoint Capital
New York
– -$3.36M -898,196 Closed
Millennium Management
168
Millennium Management
New York
– -$3.34M -893,648 Closed
HF
169
HRT Financial
New York
– -$1.48M -395,753 Closed
PAM
170
Panagora Asset Management
Massachusetts
– -$1.33M -356,740 Closed
Man Group
171
Man Group
United Kingdom
– -$945K -252,676 Closed
CSS
172
Cubist Systematic Strategies
Connecticut
– -$802K -214,345 Closed
Squarepoint
173
Squarepoint
New York
– -$660K -176,495 Closed
SOW
174
State of Wyoming
Wyoming
– -$353K -94,501 Closed
BC
175
BIT Capital
Germany
– -$333K -89,162 Closed
4 5 6
7
8

FATE Hedge Fund Activity: Q1 2024 in Review

167 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Fate Therapeutics (FATE) for Q1 2024, worth a combined $904M — up 150% from $362M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new FATE positions and 31 closed out — a net gain of 10 holders — while 48 added to existing stakes and 52 trimmed.

The largest buyer was Boxer Capital, adding an estimated $47.8M. The largest seller was BlackRock, cutting an estimated $13.1M.

  • 167 institutional investors held Fate Therapeutics (FATE) as of Q1 2024, up from 159 in Q4 2023.
  • Funds reported $904M of Fate Therapeutics stock for Q1 2024, up 150% quarter-over-quarter.
  • 41 funds opened new Fate Therapeutics positions in Q1 2024 and 31 closed out, a net change of +10 holders.
  • The largest Fate Therapeutics buyer in Q1 2024 was Boxer Capital, an estimated $47.8M added.
  • The largest Fate Therapeutics seller in Q1 2024 was BlackRock, an estimated $13.1M sold.

Based on aggregated 13F filings for Q1 2024.